Blueshift Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,364
| Closed | -$328K | – | 1363 |
|
|
2021
Q3 | $328K | Sell |
2,364
-12,735
| -84% | -$1.77M | 0.02% | 777 |
|
|
2021
Q2 | $1.47M | Buy |
+15,099
| New | +$1.47M | 0.08% | 272 |
|
|
2020
Q4 | – | Sell |
-4,253
| Closed | -$276K | – | 960 |
|
|
2020
Q3 | $276K | Sell |
4,253
-4,731
| -53% | -$307K | 0.04% | 477 |
|
|
2020
Q2 | $657K | Buy |
+8,984
| New | +$657K | 0.11% | 268 |
|
|
2019
Q4 | – | Sell |
-17,064
| Closed | -$712K | – | 1139 |
|
|
2019
Q3 | $712K | Buy |
17,064
+8,970
| +111% | +$374K | 0.11% | 272 |
|
|
2019
Q2 | $354K | Sell |
8,094
-13,390
| -62% | -$586K | 0.05% | 484 |
|
|
2019
Q1 | $1.11M | Buy |
21,484
+13,202
| +159% | +$680K | 0.16% | 215 |
|
|
2018
Q4 | $306K | Buy |
+8,282
| New | +$306K | 0.06% | 484 |
|